Clinical trial / 2025
Neither cocoa extract nor multivitamin/multimineral supplementation reduced incident fracture risk in older adults.
In an ancillary study to the COSMOS trial, 21,442 older adults were randomized to receive daily cocoa extract (500 mg/d flavanols, 80 mg/d (-)-epicatechin), a daily multivitamin/multimineral (MVM; Centrum Silver), both, or placebos for a median of 3.6 years. During follow-up, 2,083 incident clinical fractures occurred. Compared with placebo, cocoa extract did not significantly reduce the risk of incident clinical fracture (aHR 1.03, 95% CI 0.95-1.12) or nonvertebral fracture (aHR 1.05, 95% CI 0.96-1.14). Similarly, MVM supplementation was not associated with lower risk of total clinical fracture (aHR 1.09, 95% CI 1.00-1.19), hip fracture (aHR 1.06, 95% CI 0.80-1.42), or nonvertebral fracture (aHR 1.10, 95% CI 1.00-1.20).
- Study type
- Randomized controlled trial (2x2 factorial)
- Who was studied
- 21,442 older adults (12,666 females aged >=65 yr and 8,776 males aged >=60 yr)
- What was measured
- Total clinical fracture, hip fracture, nonvertebral fracture, and other fractures
THE PAPER
Effects of cocoa extract supplementation and multivitamin/multimineral supplements on self-reported fractures in the Cocoa Supplement and Multivitamins Outcomes Study randomized clinical trial.
Crandall CJ, Chou S, Kim E, Ratnarajah D, Cook NR, Clar A, Sesso HD, Manson JE, LeBoff MS. J Bone Miner Res, 2025.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.